Bodamer Olaf A, Johnson Britt, Dajnoki Angela
Division of Clinical and Translational Genetics, Dr. John T. MacDonald Foundation, Department of Human Genetics, University of Miami Miller School of Medicine, Miami, FL, USA.
Curr Protoc Hum Genet. 2013;Chapter 17:Unit17.13. doi: 10.1002/0471142905.hg1713s77.
Fabry disease (FD) is an X-linked lysosomal storage disorder due to deficiency of alpha galactosidase A (GLA). Progressive, intralysosomal accumulation of neutral glycosphingolipids in endothelial cells and podocytes leads to multi-organ involvement in affected males and to a lesser extent in affected females. Diagnosis of FD is based on GLA analysis in leukocytes or dried blood spots (DBS) in FD males while GLA activities may be within the normal range in FD females. The advent of fluorometric and mass spectrometry methods for enzyme analysis in DBS has simplified the diagnostic approach for FD males, facilitating high-throughput screening of at risk populations and newborn infants. However, the diagnostic mainstay for FD females remains molecular analysis of the GLA gene. The following unit will provide the detailed analytical protocol for measurement of GLA activity in DBS using tandem mass spectrometry.
法布里病(FD)是一种X连锁溶酶体贮积症,由α-半乳糖苷酶A(GLA)缺乏所致。内皮细胞和足细胞中中性糖鞘脂在溶酶体内进行性蓄积,导致患病男性多器官受累,患病女性受累程度较轻。FD的诊断基于对FD男性白细胞或干血斑(DBS)中的GLA进行分析,而FD女性的GLA活性可能在正常范围内。用于DBS中酶分析的荧光法和质谱法的出现简化了FD男性的诊断方法,便于对高危人群和新生儿进行高通量筛查。然而,FD女性的主要诊断方法仍然是对GLA基因进行分子分析。以下单元将提供使用串联质谱法测量DBS中GLA活性的详细分析方案。